NIH state-of-the-science conference statement: Enhancing use and quality of colorectal cancer screening.

Donald Steinwachs, Jennifer Dacey Allen, William Eric Barlow, R Paul Duncan, Leonard E Egede, Lawrence S Friedman, Nancy L Keating, Paula Kim, Judith R Lave, Thomas A LaVeist, Roberta B Ness, Robert J Optican, Beth A Virnig
{"title":"NIH state-of-the-science conference statement: Enhancing use and quality of colorectal cancer screening.","authors":"Donald Steinwachs,&nbsp;Jennifer Dacey Allen,&nbsp;William Eric Barlow,&nbsp;R Paul Duncan,&nbsp;Leonard E Egede,&nbsp;Lawrence S Friedman,&nbsp;Nancy L Keating,&nbsp;Paula Kim,&nbsp;Judith R Lave,&nbsp;Thomas A LaVeist,&nbsp;Roberta B Ness,&nbsp;Robert J Optican,&nbsp;Beth A Virnig","doi":"","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>To provide health care providers, patients, and the general public with a responsible assessment of currently available data on enhancing use and quality of colorectal cancer screening.</p><p><strong>Participants: </strong>A non-DHHS, nonadvocate 13-member panel representing the fields of cancer surveillance, health services research, community-based research, informed decision-making, access to care, health care policy, health communication, health economics, health disparities, epidemiology, statistics, thoracic radiology, internal medicine, gastroenterology, public health, end-of-life care, and a public representative. In addition, 20 experts from pertinent fields presented data to the panel and conference audience.</p><p><strong>Evidence: </strong>Presentations by experts and a systematic review of the literature prepared by the RTI International-University of North Carolina Evidence-based Practice Center, through the Agency for Healthcare Research and Quality. Scientific evidence was given precedence over anecdotal experience.</p><p><strong>Conference process: </strong>The panel drafted its statement based on scientific evidence presented in open forum and on published scientific literature. The draft statement was presented on the final day of the conference and circulated to the audience for comment. The panel released a revised statement later that day at http://consensus.nih.gov. This statement is an independent report of the panel and is not a policy statement of the NIH or the Federal Government.</p><p><strong>Conclusions: </strong>The panel found that despite substantial progress toward higher colorectal cancer screening rates nationally, screening rates fall short of desirable levels. Targeted initiatives to improve screening rates and reduce disparities in underscreened communities and population subgroups could further reduce colorectal cancer morbidity and mortality. This could be achieved by utilizing the full range of screening options and evidence-based interventions for increasing screening rates. With additional investments in quality monitoring, Americans could be assured that all screening achieves high rates of cancer prevention and early detection. To close the gap in screening, this report identifies the following priority areas for implementation and research to enhance the use and quality of colorectal cancer screening: • Eliminate financial barriers to colorectal cancer screening and appropriate follow up. • Widely implement interventions that have proven effective at increasing colorectal cancer screening, including patient reminder systems and one-on-one interactions with providers, educators, or navigators. • Conduct research to assess the effectiveness of tailoring programs to match the characteristics and preferences of target population groups to increase colorectal cancer screening. • Implement systems to ensure appropriate follow-up of positive colorectal cancer screening results. • Develop systems to assure high quality of colorectal cancer screening programs. • Conduct studies to determine the comparative effectiveness of the various colorectal cancer screening methods in usual practice settings.</p>","PeriodicalId":86986,"journal":{"name":"NIH consensus and state-of-the-science statements","volume":"27 1","pages":"1-31"},"PeriodicalIF":0.0000,"publicationDate":"2010-02-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"NIH consensus and state-of-the-science statements","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Objective: To provide health care providers, patients, and the general public with a responsible assessment of currently available data on enhancing use and quality of colorectal cancer screening.

Participants: A non-DHHS, nonadvocate 13-member panel representing the fields of cancer surveillance, health services research, community-based research, informed decision-making, access to care, health care policy, health communication, health economics, health disparities, epidemiology, statistics, thoracic radiology, internal medicine, gastroenterology, public health, end-of-life care, and a public representative. In addition, 20 experts from pertinent fields presented data to the panel and conference audience.

Evidence: Presentations by experts and a systematic review of the literature prepared by the RTI International-University of North Carolina Evidence-based Practice Center, through the Agency for Healthcare Research and Quality. Scientific evidence was given precedence over anecdotal experience.

Conference process: The panel drafted its statement based on scientific evidence presented in open forum and on published scientific literature. The draft statement was presented on the final day of the conference and circulated to the audience for comment. The panel released a revised statement later that day at http://consensus.nih.gov. This statement is an independent report of the panel and is not a policy statement of the NIH or the Federal Government.

Conclusions: The panel found that despite substantial progress toward higher colorectal cancer screening rates nationally, screening rates fall short of desirable levels. Targeted initiatives to improve screening rates and reduce disparities in underscreened communities and population subgroups could further reduce colorectal cancer morbidity and mortality. This could be achieved by utilizing the full range of screening options and evidence-based interventions for increasing screening rates. With additional investments in quality monitoring, Americans could be assured that all screening achieves high rates of cancer prevention and early detection. To close the gap in screening, this report identifies the following priority areas for implementation and research to enhance the use and quality of colorectal cancer screening: • Eliminate financial barriers to colorectal cancer screening and appropriate follow up. • Widely implement interventions that have proven effective at increasing colorectal cancer screening, including patient reminder systems and one-on-one interactions with providers, educators, or navigators. • Conduct research to assess the effectiveness of tailoring programs to match the characteristics and preferences of target population groups to increase colorectal cancer screening. • Implement systems to ensure appropriate follow-up of positive colorectal cancer screening results. • Develop systems to assure high quality of colorectal cancer screening programs. • Conduct studies to determine the comparative effectiveness of the various colorectal cancer screening methods in usual practice settings.

美国国立卫生研究院最新科学会议声明:提高结直肠癌筛查的使用和质量。
目的:为卫生保健提供者、患者和公众提供有关提高结直肠癌筛查使用和质量的现有数据的负责任评估。参与者:一个非dhhs、非倡导者的13人小组,代表癌症监测、卫生服务研究、社区研究、知情决策、获得护理、卫生保健政策、卫生沟通、卫生经济学、卫生差异、流行病学、统计学、胸放射学、内科、胃肠病学、公共卫生、临终关怀和一名公众代表。此外,来自相关领域的20位专家向小组和会议听众介绍了数据。证据:专家介绍和北卡罗莱纳大学RTI国际循证实践中心通过卫生保健研究和质量机构编写的文献系统综述。科学证据优先于轶事经验。会议进程:小组根据公开论坛上提出的科学证据和已发表的科学文献起草了声明。声明草案在会议的最后一天提出,并分发给与会者征求意见。该委员会当天晚些时候在http://consensus.nih.gov上发布了一份修订后的声明。本声明是专家组的独立报告,不是NIH或联邦政府的政策声明。结论:专家组发现,尽管在提高全国结直肠癌筛查率方面取得了实质性进展,但筛查率仍未达到理想水平。提高筛查率和减少筛查不足社区和人群亚群差异的有针对性的举措可以进一步降低结直肠癌的发病率和死亡率。这可以通过利用全面的筛查选择和以证据为基础的干预措施来提高筛查率来实现。通过在质量监测方面的额外投资,美国人可以放心,所有筛查都能实现高癌症预防和早期发现率。为了缩小筛查方面的差距,本报告确定了以下优先实施和研究领域,以提高结直肠癌筛查的使用和质量:•消除结直肠癌筛查的经济障碍和适当的随访。•广泛实施已被证明对增加结直肠癌筛查有效的干预措施,包括患者提醒系统和与提供者、教育工作者或导航员的一对一互动。•开展研究,评估定制方案的有效性,以匹配目标人群的特征和偏好,以增加结直肠癌筛查。•实施相关制度,确保对结直肠癌筛查阳性结果进行适当的随访。•开发系统以确保结直肠癌筛查项目的高质量。•开展研究,以确定在常规情况下各种结直肠癌筛查方法的比较有效性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信